UBS Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $305
UBS Reaffirms Their Buy Rating on CME Group (CME)
CME Group Analyst Ratings
UBS Adjusts Price Target on CME Group to $305 From $290, Maintains Buy Rating
Oppenheimer Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $282
Morgan Stanley Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $304
CME Group Is Maintained at Overweight by Morgan Stanley
CME Group Price Target Raised to $304.00/Share From $301.00 by Morgan Stanley
JP Morgan Maintains Underweight on CME Group, Lowers Price Target to $211
A Quick Look at Today's Ratings for CME Group(CME.US), With a Forecast Between $269 to $297
Keefe, Bruyette & Woods Adjusts Price Target on CME Group to $273 From $265, Maintains Market Perform Rating
RBC Capital Reaffirms Their Hold Rating on CME Group (CME)
Piper Sandler Remains a Buy on CME Group (CME)
Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $283
CME Group Analyst Ratings
Deutsche Bank Adjusts Price Target on CME Group to $253 From $252
Research Alert: Cme Posts Record Results In Q1 2025
J.P. Morgan Maintains CME Group(CME.US) With Sell Rating, Raises Target Price to $223
Oppenheimer Maintains CME Group(CME.US) With Buy Rating, Raises Target Price to $279
CME Group Is Maintained at Outperform by Oppenheimer